FutureChem Co.,Ltd (KOSDAQ:220100)

South Korea · Delayed Price · Currency is KRW

6,690.00

+440.00 (7.04%)

Oct 16, 2026, 3:30 PM KST

Market Cap	180.01B -55.4%
Revenue (ttm)	20.59B +7.6%
Net Income	-11.14B
EPS	-516.80
Shares Out	26.91M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	64,259
Open	6,260.00
Previous Close	6,250.00
Day's Range	6,250.00 - 6,930.00
52-Week Range	5,341.67 - 29,208.33
Beta	0.60
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About FutureChem Co.,Ltd

FutureChem Co.,Ltd engages in the research and development, production, and sale of chemicals, pharmaceuticals, and medical devices in South Korea and internationally. The company offers radioactive pharmaceuticals, including [18F]FDG for the treatment of general cancer diagnosis, PDvue for Parkinson's disease, Alzavue for Alzheimer's disease, and FLT for the lung cancer diagnosis. Its products in pipeline include [18F]FC303, [177Lu]FC705, and 225Ac for the treatment of prostate cancer; F-FMT for brain tumor diagnosis; FC-505 for the treatment ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1999

Employees 72

Stock Exchange KOSDAQ

Ticker Symbol 220100

Full Company Profile

Financial Performance

In 2025, FutureChem Co.,Ltd's revenue was 18.67 billion, an increase of 7.96% compared to the previous year's 17.29 billion. Losses were -11.25 billion, 19.5% more than in 2024.

Financial Statements